Application 210226
- Type
- ANDA
- Sponsor
- LUPIN ATLANTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DIMETHYL FUMARATE | DIMETHYL FUMARATE | CAPSULE, DELAYED RELEASE;ORAL | 120MG | No | No |
| 002 | DIMETHYL FUMARATE | DIMETHYL FUMARATE | CAPSULE, DELAYED RELEASE;ORAL | 240MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68180-776 | DIMETHYL FUMARATE | DIMETHYL FUMARATE | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-776 | DIMETHYL FUMARATE | DIMETHYL FUMARATE | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-777 | DIMETHYL FUMARATE | DIMETHYL FUMARATE | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-777 | DIMETHYL FUMARATE | DIMETHYL FUMARATE | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-778 | DIMETHYL FUMARATE | DIMETHYL FUMARATE | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-778 | DIMETHYL FUMARATE | DIMETHYL FUMARATE | Lupin Pharmaceuticals, Inc. | ANDA | Current |